Form D — CoRegen, Inc.
0002012886-26-000003 · filed Feb 26, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $13,500,000
- Reported amount sold
- $13,500,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- CoRegen, Inc.
- CIK
- 2012886
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 801 TRAVIS STREET
HOUSTON, TX 77002 - Phone
- 858-232-5241
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Steve Gorlin · Executive OfficerHouston, TX Find on LinkedIn ↗
-
Sonal Gupta · Executive OfficerHouston, TX Find on LinkedIn ↗
-
Sonja Nelson · Executive OfficerHouston, TX Find on LinkedIn ↗
-
Bert W. O'Malley · DirectorHouston, TX Find on LinkedIn ↗
-
Edward J. Benz, Jr. · DirectorHouston, TX Find on LinkedIn ↗
-
Suneet Varma · DirectorHouston, TX Find on LinkedIn ↗
-
Lee Fleisher · DirectorHouston, TX Find on LinkedIn ↗
-
William Haseltine, PhD. · DirectorHouston, TX Find on LinkedIn ↗
-
Jonathan W. Simons · DirectorHouston, TX Find on LinkedIn ↗
-
Peter Gelinas · Executive OfficerHouston, TX Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗